COLL position history
The shares of Collegium Pharmaceutical (COLL) that THIRD AVENUE MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q4: 83,120 shares, $2.6M, 0.42% of portfolio, New
- 2024 Q1: 108,120 shares, $4.2M, 0.67% of portfolio, Add +30.1%
- 2024 Q2: 182,281 shares, $5.9M, 1.0% of portfolio, Add +68.6%
- 2024 Q3: 182,651 shares, $7.1M, 1.2% of portfolio, Add +0.2%
- 2024 Q4: 203,401 shares, $5.8M, 1.1% of portfolio, Add +11.4%
- 2025 Q1: 203,401 shares, $6.1M, 1.2% of portfolio
- 2025 Q2: 203,401 shares, $6M, 1.2% of portfolio
- 2025 Q3: 203,401 shares, $7.2M, 1.3% of portfolio
- 2025 Q4: 203,401 shares, $9.4M, 1.7% of portfolio
- 2026 Q1: 155,143 shares, $5.1M, 0.83% of portfolio, Reduce −23.7%
- 2026 Q2: 182,645 shares, $6.6M, 1.1% of portfolio, Add +17.7%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|